Ampyra and Brain neoplasm - a phase IV clinical study of FDA data

Summary:

Brain neoplasm is reported as a side effect among people who take Ampyra (dalfampridine), especially for people who are female, 60+ old, also take Tecfidera, and have Gait disturbance.

The phase IV clinical study analyzes which people have Brain neoplasm when taking Ampyra. It is created by eHealthMe based on reports of 76,998 people who have side effects when taking Ampyra from the FDA, and is updated regularly.

What is Ampyra?

Ampyra has active ingredients of dalfampridine. It is often used in multiple sclerosis. eHealthMe is studying from 77,145 Ampyra users. Check the latest studies of Ampyra.

What is Brain neoplasm?

Brain neoplasm (tumour of brain) is found to be associated with 690 drugs and 655 conditions by eHealthMe. Check the latest studies of Brain neoplasm.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 14, 2026

76,998 people reported to have side effects when taking Ampyra.
Among them, 29 people (0.04%) have Brain neoplasm.

Among these 29 people:

What is the gender of people who have Brain neoplasm when taking Ampyra? *

female: 75.86 %
male: 24.14 %

What is the age of people who have Brain neoplasm when taking Ampyra? *

What are other drugs people take besides Ampyra? *

Tecfidera: 18 people, 62.07%
Omega 3: 12 people, 41.38%
Vesicare: 12 people, 41.38%
Myrbetriq: 11 people, 37.93%
Amlodipine: 10 people, 34.48%
Cod Liver Oil: 10 people, 34.48%
Synthroid: 10 people, 34.48%
Lisinopril And Hydrochlorothiazide: 10 people, 34.48%
Fish Oil: 9 people, 31.03%
Provigil: 6 people, 20.69%

What are other side effects people have besides Brain neoplasm? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 10 people, 34.48%
Loss Of Consciousness: 6 people, 20.69%
Fall: 5 people, 17.24%
Pain In Extremity: 4 people, 13.79%
Lung Cancer Metastatic (lung cancer spreads to other parts): 4 people, 13.79%
Itching: 3 people, 10.34%
Constipation: 3 people, 10.34%
Diarrhea: 3 people, 10.34%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 6.90%
Ill-Defined Disorder: 2 people, 6.90%

What are the existing conditions these people have? *

Gait Disturbance: 11 people, 37.93%
Muscle Spasms (muscle contraction): 3 people, 10.34%
Weakness: 1 person, 3.45%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 3.45%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 1 person, 3.45%
Insomnia (sleeplessness): 1 person, 3.45%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 3.45%
Fatigue (feeling of tiredness): 1 person, 3.45%
Depression: 1 person, 3.45%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Ampyra and have Brain neoplasm?

- Check whether Brain neoplasm is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ampyra:

Ampyra (77,145 reports)

Brain neoplasm treatments and more:

Brain neoplasm (13,044 reports)

Browse all side effects of Ampyra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Brain neoplasm:

Brain neoplasm (690 drugs)

Browse all the conditions that are associated with Brain neoplasm:

Brain neoplasm (655 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dalfampridine (the active ingredients of Ampyra) and Ampyra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.